170 related articles for article (PubMed ID: 34540661)
1. "High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis".
Shraga S; Grinshpun A; Zick A; Kadouri L; Cohen Y; Maimon O; Adler-Levy Y; Zeltzer G; Granit A; Maly B; Carmon E; Meiner V; Sella T; Hamburger T; Peretz T
Front Oncol; 2021; 11():683656. PubMed ID: 34540661
[TBL] [Abstract][Full Text] [Related]
2. Prenatal diagnosis of hypoplastic left heart syndrome in current era.
Kipps AK; Feuille C; Azakie A; Hoffman JI; Tabbutt S; Brook MM; Moon-Grady AJ
Am J Cardiol; 2011 Aug; 108(3):421-7. PubMed ID: 21624547
[TBL] [Abstract][Full Text] [Related]
3. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of BRCA1 and BRCA2 Mutations Among High-risk Bahraini Patients with Breast Cancer.
Bukamal Z; AlRayes A
Gulf J Oncolog; 2023 May; 1(42):22-25. PubMed ID: 37283256
[TBL] [Abstract][Full Text] [Related]
5. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
6. The impact of prenatal diagnosis of complex congenital heart disease on neonatal outcomes.
Levey A; Glickstein JS; Kleinman CS; Levasseur SM; Chen J; Gersony WM; Williams IA
Pediatr Cardiol; 2010 Jul; 31(5):587-97. PubMed ID: 20165844
[TBL] [Abstract][Full Text] [Related]
7. Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain).
Ruiz de Sabando A; Urrutia Lafuente E; García-Amigot F; Alonso Sánchez A; Morales Garofalo L; Moreno S; Ardanaz E; Ramos-Arroyo MA
BMC Cancer; 2019 Nov; 19(1):1145. PubMed ID: 31771539
[TBL] [Abstract][Full Text] [Related]
8. Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.
Robson M; Levin D; Federici M; Satagopan J; Bogolminy F; Heerdt A; Borgen P; McCormick B; Hudis C; Norton L; Boyd J; Offit K
J Natl Cancer Inst; 1999 Dec; 91(24):2112-7. PubMed ID: 10601383
[TBL] [Abstract][Full Text] [Related]
9. A Microsimulation Model for Evaluating the Effectiveness of Cancer Risk Management for BRCA Pathogenic Variant Carriers: miBRovaCAre.
Petelin L; Hossack L; Mitchell G; Liew D; Trainer AH; James PA
Value Health; 2019 Aug; 22(8):854-862. PubMed ID: 31426925
[TBL] [Abstract][Full Text] [Related]
10. Differences between screen-detected and interval breast cancers among BRCA mutation carriers.
Pilewskie M; Zabor EC; Gilbert E; Stempel M; Petruolo O; Mangino D; Robson M; Jochelson MS
Breast Cancer Res Treat; 2019 May; 175(1):141-148. PubMed ID: 30673971
[TBL] [Abstract][Full Text] [Related]
11. Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia.
Ložar T; Žgajnar J; Perhavec A; Blatnik A; Novaković S; Krajc M
Eur J Surg Oncol; 2021 Aug; 47(8):1900-1906. PubMed ID: 33812767
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.
Lang GT; Shi JX; Hu X; Zhang CH; Shan L; Song CG; Zhuang ZG; Cao AY; Ling H; Yu KD; Li S; Sun MH; Zhou XY; Huang W; Shao ZM
Int J Cancer; 2017 Jul; 141(1):129-142. PubMed ID: 28294317
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy Associated Breast Cancer Among Israeli BRCA1/BRCA2 Carriers in a High-Risk Clinic.
Faermann R; Friedman E; Kaidar-Person O; Brodsky M; Neiman OH; Shalmon A; Gotlieb M; Yagil Y; Samocha D; Feldman DM; Weidenfeld J; Sklair-Levy M
Acad Radiol; 2023 Feb; 30(2):248-254. PubMed ID: 35527100
[TBL] [Abstract][Full Text] [Related]
14. Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis.
van Bommel MHD; IntHout J; Veldmate G; Kets CM; de Hullu JA; van Altena AM; Harmsen MG
Hum Reprod Update; 2023 Mar; 29(2):197-217. PubMed ID: 36383189
[TBL] [Abstract][Full Text] [Related]
15. Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland.
Pallonen TA; Lempiäinen SMM; Joutsiniemi TK; Aaltonen RI; Pohjola PE; Kankuri-Tammilehto MK
Sci Rep; 2022 Apr; 12(1):6704. PubMed ID: 35469032
[TBL] [Abstract][Full Text] [Related]
16. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A
Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
[TBL] [Abstract][Full Text] [Related]
18. Overview on population screening for carriers with germline BRCA mutation in China.
Lei H; Zhang M; Zhang L; Hemminki K; Wang XJ; Chen T
Front Oncol; 2022; 12():1002360. PubMed ID: 36439508
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation.
Ye F; Huang L; Lang G; Hu X; Di G; Shao Z; Cao A
Cancer Med; 2020 Mar; 9(5):1903-1910. PubMed ID: 31912664
[TBL] [Abstract][Full Text] [Related]
20. Interventions to improve psychosocial well-being in female BRCA-mutation carriers following risk-reducing surgery.
Jeffers L; Reid J; Fitzsimons D; Morrison PJ; Dempster M
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD012894. PubMed ID: 31595976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]